I'm surprised no one has discussed this.
Mithra now owns a significant chunk of Mayne pharma and this is a significant milestone.
There will likely be pressure on Mayne pharma to do better from Mithra, particularly as Mithra was promised a board member position as well.
I still feel like it's going to take actual sales figures to change sentiment on this stock but this could be a turning point.
Ann: Appendix 2A and Notice under ASX Listing Rule 3.10A, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.99 |
Change
-0.160(3.11%) |
Mkt cap ! $404.6M | |||
| Open | High | Low | Value | Volume |
| $5.05 | $5.09 | $4.97 | $352.3K | 70.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 26629 | $4.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.00 | 459 | 5 |
View Market Depth
| Last trade - 13.59pm 31/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |